You searched for "LASIK"

943 results found

Pathophysiology of diabetic macular oedema: why combination therapy may be better

The prevalence of diabetes has continued to increase over the years. It is currently estimated that there are 382 million with diabetes worldwide in 2013, and that this figure is expected to rise to 592 million by 2035 [1]. In...

Building capacity for diabetic retinopathy services in Malawi

Screening for diabetic retinopathy prevents blindness. There is no systematic screening programme for diabetic eye disease in Malawi and people present when they have lost vision and it is too late for treatment. The aim of the VISION 2020 LINK...

Do steroids prevent progression to proliferative diabetic retinopathy (PDR)?

There is continuing debate on the merits of pan-retinal photocoagulation (PRP) for severe pre-proliferative and proliferative DR versus the newer therapies that inhibit vascular endothelial growth factor (VEGF). This has been hotly debated [1] following the publication of findings from...

Fight for Sight and The Royal College of Ophthalmologists invite applications for John Lee Primer Fellowships for research into sight loss

In partnership with The Royal College of Ophthalmologists, Fight for Sight is now inviting applications for its John Lee Primer Fellowships, offering up to £60,000 to support early career ophthalmologists to undertake ground-breaking vision research.

One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperative management

The authors report a retrospective, non-randomised interventional case series of 39 patients who underwent a standalone XEN45 implantation. All 39 patients (female: male=1.2: 1) completed 12-month follow-up. Mean age was 70.1 years (range 32–92). Primary outcome measures were the intraocular...

IN FOCUS - The achievements and lasting effects of VISION 2020

Blindness is a major public health problem globally. The first estimate of global blindness by the World Health Organization (WHO) in 1972 provided a figure of 10 to 15 million, which was considered an underestimate [1]. In 1999, an extraordinary...

Real-world experience and outcomes of SLT laser used as a first-line treatment in ocular hypertension patients in a United Kingdom National Health Service setting

The management of raised intraocular pressure (IOP) in the context of ocular hypertension (OHT) and primary open angle glaucoma (POAG) remains a major contributor to the workload of ophthalmology units across the UK. Treatment of these conditions has historically centred...

Developing eye health services in Malawi: a personal reflection

Dr Chinsisi Namate reflects on her first two years as a consultant ophthalmologist at the eye unit at Zomba Central Hospital, and how she has already successfully expanded eyecare services for southeast Malawi. The Lions Sight First Eye Hospital in...

Scholarships, awards and prizes

Perhaps one of the less well-known benefits of being a member of the Royal College of Ophthalmologists (RCOphth) is access to the range of scholarships, awards and prizes that we offer. Many of you will be aware of the annual...

Developing community eye care: the GOS package in Scotland

In the second in the series about community eye care in the home nations, Janet Pooley explains how Scotland has developed its services within GOS. The United Kingdom has devolved healthcare; the powers were transferred from Westminster to Scotland and...

Management of DMO and PDR in 2019

An evidence-based approach to the management of diabetic macular oedema (DMO) and proliferative diabetic retinopathy (PDR) in 2019 was outlined by Sobha Sivaprasad, UK, in presentations during the Diabetic Retina scientific session September 6 2019, at the 19th European Society...

The results of the last survey Dec23

*Please be aware that this data does not form part of a peer reviewed research study. The information therein should not be relied upon for clinical purposes but instead used as a guide for clinical practice and reflection. Hopefully by...